Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months.

@article{Perrins1995PulmonaryTI,
  title={Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months.},
  author={Jos Perri{\"e}ns and Michael E. St. Louis and Y B Mukadi and Charles Brown and Jacques J. Prignot and F. Pouthier and Françoise Portaels and J. C. Willame and J K Mandala and M Kaboto},
  journal={The New England journal of medicine},
  year={1995},
  volume={332 12},
  pages={779-84}
}
BACKGROUND We studied the efficacy of a short-course regimen of chemotherapy for pulmonary tuberculosis in Kinshasa, Zaire. We also assessed whether, among patients with human immunodeficiency virus (HIV) infection, treatment should be extended from 6 to 12 months. METHODS HIV-seropositive and HIV-seronegative outpatients with pulmonary tuberculosis were treated with rifampin, isoniazid, pyrazinamide, and ethambutol daily for two months, followed by rifampin plus isoniazid twice weekly for… CONTINUE READING
Highly Influential
This paper has highly influenced 10 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
86 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 86 extracted citations

Similar Papers

Loading similar papers…